Showing results (81-90 of 117) with videos related to
Sort By:
Pageof 12
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 19, 2025
Age-dependent response to initial highly effective treatment in relapsing multiple sclerosisEmilio Portaccio, Matteo Betti, Ermelinda De Meo, et al.International Journal of Medical Informatics|June 10, 2026
Web-based family-reported outcomes to assess family functioning in multiple sclerosis: an Italian multicenter digital surveyLuigi Lavorgna, Giuseppina Miele, Marta Ponzano, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 23, 2023
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY)Clara G Chisari, Assunta Bianco, Vincenzo Brescia Morra, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 28, 2019
Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?Marinella Clerico, Stefania Federica De Mercanti, Alessio Signori, et al.Journal of the Neurological Sciences|March 26, 2021
MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian studyStefania Federica De Mercanti, Alessio Signori, Cinzia Cordioli, et al.Journal of Neurology|August 6, 2025
Real-world comparison of lymphopenia profiles in S1P receptor modulators for multiple sclerosis: a multicenter retrospective studyGiorgia Teresa Maniscalco, Maddalena Sparaco, Maria Di Gregorio, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|November 19, 2020
Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factorsPietro Iaffaldano, Giuseppe Lucisano, Francesco Patti, et al.European Journal of Neurology|March 29, 2024
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop)Irene Schiavetti, Alessio Signori, Angela Albanese, et al.Annals of Neurology|February 12, 2022
Comparing Natural History of Early and Late Onset Pediatric Multiple SclerosisErmelinda De Meo, Massimo Filippi, Maria Trojano, et al.Annals of Clinical and Translational Neurology|July 7, 2025
Early Intensive Versus Escalation Approach: Ten-Year Impact on Disability in Relapsing Multiple SclerosisPietro Iaffaldano, Giuseppe Lucisano, Tommaso Guerra, et al.Pageof 12